• Big announcement and Hepatic impairment studies (Ep. 22)

  • Mar 25 2024
  • Length: 18 mins
  • Podcast

Big announcement and Hepatic impairment studies (Ep. 22)

  • Summary

  • Today’s show is about hepatic impairment clinical studies. I cover the rationale behind evaluating hepatic impairment, common study designs, and key factors in the analysis and interpretation of the study results. I also share a huge announcement about Aplos NCA, a cloud-based solution for calculating NCA PK parameters. Use the link below to learn more about Aplos NCA.

    Links discussed in the show:

    • FDA guidance
    • EMA guideline
    • Aplos Analytics website
    • You can connect with me on LinkedIn and send me a message
    • Send me a message
    • Sign up for my newsletter


    Copyright Teuscher Solutions LLC

    Show more Show less

What listeners say about Big announcement and Hepatic impairment studies (Ep. 22)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.